Raymond James Financial’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.6M Buy
867,776
+69,982
+9% +$983K ﹤0.01% 1814
2026
Q1
$9.51M Buy
797,794
+96,705
+14% +$1.39M ﹤0.01% 2066
2025
Q4
$10.8M Sell
701,089
-132,548
-16% -$2.44M ﹤0.01% 1901
2025
Q3
$18M Buy
833,637
+215,377
+35% +$4.8M 0.01% 1485
2025
Q2
$13.7M Buy
618,260
+21,098
+4% +$469K ﹤0.01% 1634
2025
Q1
$14.2M Buy
597,162
+118,674
+25% +$2.81M 0.01% 1550
2024
Q4
$10.1M Buy
+478,488
New +$12.6M ﹤0.01% 1834

Other funds holding SGRY

Raymond James Financial's SGRY Position: Q2 2026 in Review

Raymond James Financial increased its Surgery Partners (SGRY) stake by 8.8% in Q2 2026, buying an estimated $983K and bringing the position to 867,776 shares worth $14.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1814.

Raymond James Financial first reported a position in SGRY in Q4 2024 and has held it in 7 quarters since. The position peaked at $18M in Q3 2025. 187 funds tracked by Wall St. Rank hold SGRY as of Q2 2026.

  • Raymond James Financial held 867,776 shares of Surgery Partners worth $14.6M as of Q2 2026.
  • Raymond James Financial bought 69,982 Surgery Partners shares in Q2 2026, an estimated $983K.
  • Surgery Partners made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #1814 holding.
  • Raymond James Financial first reported a position in Surgery Partners in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Surgery Partners position peaked at $18M in Q3 2025.
  • 187 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.